Pokorná, Zuzana
Tylichová, Zuzana
Vojtesek, Borivoj
Coates, Philip J.
Funding for this research was provided by:
Ministry of Health, Czech Republic (MMCI 00209805, MMCI 00209805)
Czech Science Foundation (GACR 23-05951S)
Article History
Received: 26 October 2023
Accepted: 22 March 2024
First Online: 27 March 2024
Competing interests
: BV is a consultant for Moravian Biotechnology, which supplied the p63 antibodies used in this study. The company had no role in the design, execution, interpretation, or writing of the study. All other authors declare no conflict of interest.